Pediatric Brain Cancer:
U.S. Phase 1 Clinical Trial
Not Yet Recruiting
Pediatric Brain
Cancer: U.S. Phase
1 Clinical Trial
Not Yet Recruiting
Pediatric
Brain
Cancer:
U.S. Phase
1 Clinical
Trial
Not Yet Recruiting
Principal Investigators
There is a physician who is responsible for the scientific and technical direction of the clinical trial at each location.
Ashley S. Plant, M.D.
Lurie Children’s Hospital of Chicago
SPECIALTIES: CANCER & BLOOD DISORDERS
Ashley S. Plant, M.D. is an attending physician in neuro-oncology at Ann and Robert H. Lurie Children’s Hospital of Chicago and is an Assistant Professor of Pediatrics at Northwestern University. Dr. Plant received her medical degree from Stanford University School of Medicine. She completed her pediatrics residency at University of California, Los Angeles and her pediatric hematology/oncology fellowship at Dana Farber Cancer Institute/Boston Children’s Hospital. She completed additional training in neuro-oncology at Dana Farber Cancer Institute. Her research focus includes immunotherapy and the immune microenvironment as well as early phase clinical trial design for pediatric brain tumors.
Trial Locations
Please visit this website regularly for updates as new locations are added.
Lurie Children’s Hospital
Chicago, Illinois
What Can You Do Next?
Participating in a clinical trial is an important decision. If you believe this clinical trial might be a good fit and are interested in participating, please take the next step to see if you are eligible.
Request Information
News
November 29, 2023
Plus Therapeutics to Present at the 5th Targeted Radiopharmaceuticals Summit Europe
- Presentation titled “Re-186 Radiolabelled NanoLiposomes for Rare Brain and Spinal Cord Tumors”
June 8, 2023
- Plus Therapeutics announced it will exhibit at both the Society for NeuroOncology’s (SNO) Pediatric Conference, taking place June 22-24, 2023 in Washington, D.C., and the Society of Nuclear Medicine & Molecular Imaging’s (SNMMI) Annual Meeting, taking place June 24-27, 2023 in Chicago, Illinois.
August 21, 2021
June 10, 2021
Plus Therapeutics Presents at the Sixth Biennial Pediatric Neuro-Oncology Research Conference
Publications
Posters
Resources
Note: all external links
- American Brain Tumor Association
- American Cancer Society
- American Childhood Cancer Organization
- Brain Tumor Network
- Dictionary of Cancer Terms
- End Brain Cancer Initiative
- Ependymoma Cancer Research Network
- MedlinePlus (NIH)
- National Brain Tumor Society
- National Cancer Institute
- National Comprehensive Cancer Network
- Pediatric Brain Tumor Foundation
- Support Groups Listing
- The Brain Tumour Charity
- Trial Connect
- VirtualTrials.com
- Voices Against Brain Cancer
Updates
$5.7 Million PSTV Funding
Plus Therapeutics Secures $5.7 Million in Funding to Advance Cancer Research #PSTV News: Plus Therapeutics has successfully closed a private placement with $3.7 million in upfront proceeds and received a $2.0 million advance payment from the Cancer Prevention and...
February is Patient Appreciation Month!
Celebrating Strength and Resilience: Patient Appreciation Month At Plus Therapeutics, we are honored to celebrate #PatientAppreciationMonth and recognize the incredible strength, resilience, and courage of patients facing cancer. 🧡 Every day, we are inspired by those...
#WorldCancerDay2025
Honoring Progress and Hope on World Cancer Day 🔬 Today is #WorldCancerDay, a day dedicated to raising awareness, advancing research, and supporting those affected by cancer. At Plus Therapeutics, we recognize the unwavering dedication of patients, caregivers, and...
YouTube Channel
Catch Up on Our Latest Videos – Now on YouTube! Did you miss any of our recent videos? Don't worry—they're all available on our Plus Therapeutics YouTube channel! 🔹 Stay informed with expert discussions on cutting-edge cancer research. 🔹 Hear from patients sharing...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Contents
- 1 Pediatric Brain Cancer:U.S. Phase 1 Clinical Trial
- 1.1 Pediatric BrainCancer: U.S. Phase1 Clinical Trial
- 1.2 PediatricBrainCancer:U.S. Phase1 ClinicalTrial
- 1.3 Trial Information
- 1.4 “Children with brain tumors have limited options & 186RNL (REYOBIQ™) delivered with a minimally invasive procedure could be an important new potential option for these patients.”
- 1.5 Principal Investigators
- 1.6 Trial Locations
- 1.7 What Can You Do Next?
- 1.8 Request Information
- 1.9 News
- 1.10 Publications
- 1.11 Resources
- 1.12 Updates
- 1.13 $5.7 Million PSTV Funding
- 1.14 February is Patient Appreciation Month!
- 1.15 #WorldCancerDay2025
- 1.16 YouTube Channel
- 1.17 No Results Found